Navigation Links
Cord Blood America Announces First Storage Sale in Germany; Commitment to Expansion

SANTA MONICA, Calif., April 9 /PRNewswire-FirstCall/ -- Cord Blood America, Inc. (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company ( focused on bringing the life saving potential of stem cells to families nationwide and internationally, said that its international partner, a.bourkas Co., United, Greece, has established a sales operation, and completed their first sale in Germany.

"Europe is starting to look more closely at the collection and storage of umbilical cord blood, which contains stem cells that could be useful for treatment of diabetes, heart disease and other illnesses that are currently impossible to cure," said Matthew Schissler, Cord Blood America Founder and CEO.

"We have been in a partnership in Greece since 2006 and we are very encouraged by their efforts to bring this life saving process to other nations on the European continent," Mr. Schissler said. "We see this as a new, potentially very profitable frontier and we are pleased to be among the leaders in this effort. We are committed to expansion and growth."

About Cord Blood America

Cord Blood America (OTC Bulletin Board: CBAI) is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc. (OTC Bulletin Board: CBAI), visit our website at For investor information, visit

    Paul Knopick
    E & E Communications

SOURCE Cord Blood America, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Blood tests reveal tobacco smoke residues in non-smoking New Yorkers
2. Growth factor TGF-B helps maintain health of retinal blood vessels
3. Global Med Technologies(R), Inc. Licenses Its Leading European Blood and Laboratory Solutions to Homburg, Germany Clinic Blood Center
4. CVS Caremark Study Documents Changes in Prescription Drug Use to Treat High Blood Pressure, High Cholesterol and Diabetes in Children and Adolescents
5. More U.S. Kids Taking Diabetes, Blood Pressure Drugs
6. Stem cell therapy grows new blood vessels
7. Cord Blood Announces $1.75 Million Reduction in Long Term Debt
8. Arthritis Trial Leads to Potential Cure for High Blood Pressure
9. World-first high blood pressure treatment trialled in Melbourne
10. Haemonetics Bolsters Blood Bank Information Management Portfolio With Acquisition of Altivation Software
11. Blood, Marrow Drive Offers Hope for Baseball Player, 15
Post Your Comments:
(Date:12/1/2015)... , ... December 01, 2015 , ... ... of Excellence (BHCOE) today announced that the organization has awarded Education and Developmental ... with a Distinguished Award. The award celebrates exceptional special needs providers that excel ...
(Date:12/1/2015)... MA (PRWEB) , ... December 01, 2015 , ... Lutronic, ... release of Clarity, the latest addition to the devices for sale in the United ... 755 nm Alexandrite and long-pulsed 1064 nm Nd:YAG lasers, into a single platform that ...
(Date:12/1/2015)... (PRWEB) , ... December 01, 2015 , ... XTC ... selected 10 semi-finalists to head to Las Vegas for CES 2016, the world’s largest ... CEO of Consumer Technology Association Gary Shapiro, Founding Partner of Pacific Investments Veronica Serra, ...
(Date:12/1/2015)... ... , ... Nurotron Biotechnology Co., Ltd., maker of cochlear implant systems, has won ... order will be from the China Disabled Persons’ Federation, a central government association, for ... for children and adults suffering from severe and profound hearing loss . The ...
(Date:12/1/2015)... IL (PRWEB) , ... December 01, 2015 , ... ... Unified Contact Center Enterprise Authorized Technology Provider (ATP) status from Cisco. This designation ... deploy and support Cisco Unified Contact Center solutions targeted to the high-end enterprise ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... December 1, 2015 --> ... research report "Nucleic Acid Labeling Market by Product (Reagents ... Random Primer, In Vitro Transcription, Reverse Transcription, End Labeling), ... MarketsandMarkets, The global market is expected to reach USD ... 2015, growing at a CAGR of 8.65%. ...
(Date:12/1/2015)... , Dec. 01, 2015 ... announced the addition of the ... Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, ... report to their offering. --> ... addition of the "2016 Europe ...
(Date:12/1/2015)... ANGELES , Dec. 1, 2015 CytRx ... development company specializing in oncology, today announced that it ... the company,s pivotal global Phase 3 clinical trial of ... (STS). Enrollment was originally estimated to be completed in Q1 ... being conducted under a Special Protocol Assessment from the ...
Breaking Medicine Technology: